Mark Lynn Unruh

Mark Lynn Unruh

Auto-generated profile, based on publicly available information

Mark Lynn Unruh

Renal-Electrolyte Division, University of Pittsburgh Medical Center, Pittsburgh, Pa., USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2008 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
PDF file
MJManisha Jhamb
Manisha Jhamb
SWSteven D. Weisbord
Steven D. Weisbord
JSJennifer L. Steel
Jennifer L. Steel
MUMark Unruh
Mark Unruh

1 July 2008 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
MUMark L. Unruh
Mark L. Unruh
SRSusan Redline
Susan Redline
MAMing‐Wen An
Ming‐Wen An
DBDaniel J. Buysse
Daniel J. Buysse
FNF. Javier Nieto
F. Javier Nieto
ANAnne B. Newman
Anne B. Newman

1 May 2004 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
MUMark L Unruh
Mark L Unruh
ALAndrew S Levey
Andrew S Levey
CDCarolyn D'AMbrosio
Carolyn D'AMbrosio
NFNancy E Fink
Nancy E Fink
NPNeil R Powe
Neil R Powe
KMKlemens B Meyer
Klemens B Meyer

1 November 2009 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
MJManisha Jhamb
Manisha Jhamb
CAChristos Argyropoulos
Christos Argyropoulos
JSJennifer L. Steel
Jennifer L. Steel
LPLaura Plantinga
Laura Plantinga
AWAlbert W. Wu
Albert W. Wu
FSfor the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study
for the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study
Background & objectives: Fatigue is a debilitating symptom experienced by patients undergoing dialysis, but there is only limited information on its prevalence and its association with patient outcomes. This study examines the correlates of self-reported fatigue at initiation of dialysis and after 1 yr and assesses the extent to which fatigue was associated with health-related quality of life and survival. Design, setting, participants, & measurements: A longitudinal cohort of 917 incident hemodialysis and peritoneal dialysis patients who completed the CHOICE Health Experience Questionnaire (CHEQ) participated in the study. Fatigue was assessed using the SF-36 vitality scale. Known predictors of fatigue including sociodemographic and psychosocial factors, dialysis-related factors, biochemical variables including inflammatory markers, comorbidities, and medications were used as covariates. Results: A low vitality score was independently associated with white race, higher Index of Coexistent Disease score, higher body mass index, lack of physical exercise, antidepressant use, and higher C-reactive protein levels (CRP). A lower vitality score was strongly associated with lower SF-36 physical functioning, mental health, bodily pain scores, and decreased sleep quality (all P < 0.001) at baseline. Among surviving participants, higher serum creatinine at baseline was associated with preserved vitality at 1 yr. Patients with the highest baseline vitality scores were associated with longer survival (hazard ratio 0.75; 95% CI 0.58 to 0.96, P = 0.03). Conclusions: The findings of this study demonstrate that ESRD patients experience profound levels of fatigue and elucidate its correlates. Also, the association of fatigue with survival may have significant implications for this population.

1 March 2010 in Current Opinion in Nephrology and Hypertension
Verified
Journal Article
Closed access
RSRitu K Soni
Ritu K Soni
SWSteven D Weisbord
Steven D Weisbord
MUMark L Unruh
Mark L Unruh
Purpose of review Patients with chronic kidney disease (CKD) endure compromised health-related quality of life (HRQOL). Although the link between HRQOL and increased mortality in patients with end-stage renal disease (ESRD) is well documented, less is known about the relationship between CKD and HRQOL. This article reviews the recent evidence on HRQOL, its correlates and proposed intervention strategies to improve HRQOL in CKD. Recent findings A growing body of literature indicates that various comorbid conditions related to CKD play a substantial role in impaired HRQOL in CKD. Hypertension, both a cause and complication of CKD, negatively affects HRQOL due to associated comorbidities, side effects from antihypertensive medications and awareness of the diagnosis. Anemia has been associated with HRQOL, but concerns about the safety of erythropoietin-stimulating agents (ESAs) have led to more conservative anemia treatment. Frailty, symptom burden and depression are also major contributory factors to HRQOL in CKD. Summary Certain determinants of HRQOL in CKD, namely anemia and depression, are treatable. Early identification and correction may improve overall well being of patients. Clinical trials are required to demonstrate whether treatment interventions benefit HRQOL in this high-risk population. Furthermore, whether integration of HRQOL assessment into routine clinical practice will improve HRQOL outcomes remains to be determined.

1 July 2004 in Kidney International
Verified
Journal Article
Closed access
MUMark Unruh
Mark Unruh
RBRobert Benz
Robert Benz
TGTom Greene
Tom Greene
GYGuofen Yan
Guofen Yan
SBSrinivasan Beddhu
Srinivasan Beddhu
KMKlemens B. Meyer
Klemens B. Meyer